A detailed history of Israel Englander (Millennium Management LLC) transactions in Medicinova Inc stock. As of the latest transaction made, Millennium Management LLC holds 20,453 shares of MNOV stock, worth $37,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,453
Previous 24,886 17.81%
Holding current value
$37,224
Previous $35,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.13 - $2.1 $5,009 - $9,309
-4,433 Reduced 17.81%
20,453 $42,000
Q2 2024

Aug 14, 2024

SELL
$1.28 - $1.57 $6,607 - $8,104
-5,162 Reduced 17.18%
24,886 $35,000
Q1 2024

May 15, 2024

SELL
$1.28 - $1.65 $8,117 - $10,464
-6,342 Reduced 17.43%
30,048 $43,000
Q4 2023

Feb 14, 2024

SELL
$1.38 - $2.06 $254,356 - $379,690
-184,316 Reduced 83.51%
36,390 $54,000
Q2 2023

Aug 14, 2023

SELL
$2.09 - $2.43 $65,281 - $75,901
-31,235 Reduced 12.4%
220,706 $507,000
Q1 2023

May 15, 2023

BUY
$1.95 - $2.54 $614 - $800
315 Added 0.13%
251,941 $544,000
Q4 2022

Feb 14, 2023

SELL
$1.97 - $2.66 $199,620 - $269,537
-101,330 Reduced 28.71%
251,626 $516,000
Q3 2022

Nov 14, 2022

SELL
$2.1 - $2.6 $6,230 - $7,714
-2,967 Reduced 0.83%
352,956 $766,000
Q2 2022

Aug 15, 2022

SELL
$2.31 - $3.14 $50,517 - $68,668
-21,869 Reduced 5.79%
355,923 $900,000
Q1 2022

May 16, 2022

SELL
$2.19 - $2.81 $29,405 - $37,729
-13,427 Reduced 3.43%
377,792 $1.01 Million
Q4 2021

Feb 14, 2022

BUY
$2.61 - $4.42 $29,232 - $49,504
11,200 Added 2.95%
391,219 $1.05 Million
Q3 2021

Nov 15, 2021

SELL
$3.4 - $4.24 $1.02 Million - $1.27 Million
-299,784 Reduced 44.1%
380,019 $1.44 Million
Q2 2021

Aug 16, 2021

BUY
$3.76 - $5.14 $2.56 Million - $3.49 Million
679,803 New
679,803 $2.89 Million
Q1 2021

May 17, 2021

SELL
$4.81 - $8.74 $189,124 - $343,648
-39,319 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$5.03 - $6.31 $197,774 - $248,102
39,319 New
39,319 $207,000
Q3 2020

Nov 16, 2020

SELL
$4.67 - $11.0 $90,906 - $214,126
-19,466 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$3.06 - $7.06 $49,067 - $113,207
-16,035 Reduced 45.17%
19,466 $106,000
Q1 2020

May 14, 2020

SELL
$2.9 - $6.97 $178,010 - $427,839
-61,383 Reduced 63.36%
35,501 $132,000
Q4 2019

Feb 14, 2020

BUY
$6.48 - $8.76 $627,808 - $848,703
96,884 New
96,884 $653,000
Q3 2019

Nov 14, 2019

SELL
$7.7 - $10.42 $869,961 - $1.18 Million
-112,982 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$8.29 - $13.22 $936,620 - $1.49 Million
112,982 New
112,982 $1.09 Million

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $89.3M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.